Revenue

Amid market volatility, Houston's Marble Capital hires Doug Goff to lead a new open-end fund, doubling down on its Sunbelt multifamily strategy.

Verdiva Bio's VRB-101 aims to be the first once-weekly oral GLP-1, a potential game-changer for patients tired of daily pills and injections.

A new partnership with Ukraine's Kemitura gives LBB Specialties access to key materials, reshaping the North American chemical supply chain.

Groundbreaking research shows AI's information diet is dangerously imbalanced, creating an unseen force that could manipulate public opinion and erode democracy.

Metrie acquires three Owens Corning door businesses, its eighth purchase since 2020, signaling a major shift toward integrated building solutions.

The $20B wealth firm appoints a veteran partner as its first CEO, signaling a new era of strategic growth while doubling down on its core values.

A new security framework from Crittora aims to eliminate a core AI vulnerability, making autonomous agents enterprise-ready and setting a new trust standard.

A planned reverse merger for promising vaccine developer SVF Vaccines has collapsed after Nasdaq rejected the deal, leaving its lead investor scrambling.

With 1,000 employers on board, TIAA and Nuveen's lifetime income funds are bringing pension-like certainty back to the 401(k) for over 1 million workers.

A massive new study finds ECGs save young lives, questioning UK policy as 12 die weekly from hidden heart conditions. Is repeat screening the answer?

The insurer is expanding API integrations with major HR platforms like ADP and Workday, a strategic move to simplify benefits and gain a competitive edge.

A new partnership aims to end the fragmented and costly process of healthcare compliance by merging a GRC platform with expert assessment services.

Wendi Weiner, a top legal career expert, will guide the nation's leading legal search consultants at the NALSC conference on navigating a transformed job market.

A landmark private equity deal sees Specialty Fenestration Group sold after explosive growth, signaling a boom in the high-security solutions market.

As Fred Strong and Jewel Edson take the helm of the LOSSAN rail agency, they face urgent threats of coastal erosion, funding battles, and infrastructure needs.

A landmark study confirms a minimally invasive radiofrequency device is highly effective for chronic rhinitis, offering lasting relief beyond traditional sprays.

With new backing from One Six 8 Ventures, health tech firm Respiree accelerates its US and Canadian expansion of its FDA-cleared AI platform.

Komar Industries' acquisition of Metro Compactor creates a cross-border powerhouse, combining U.S. manufacturing with Canadian service and IoT technology.

The tech firm announced progress on a major health contract, but with its stock near all-time lows, can this deal deliver a much-needed turnaround?

The legacy brand blends heritage, market strategy, and conservation with its new 8-year bourbon, inspired by 19th-century decanters and now available nationwide.